Descoperiri ale fizicii cuantice, cu impact major asupra vieþii noastre

Noi gândim încontinuu, fie cã vrem sau nu aceasta. Fiecare dintre noi are aproximativ 60.000 de gânduri pe zi.
Iar toate aceste gânduri ale noastre produc consecinþe, pentru cã fiecare gând este de fapt o energie pe care o lansãm în Univers ºi nu doar în direcþia doritã, ci în toate direcþiile.
Energia emisã de gândurile noastre îºi cautã apoi, în drumul ei, o altã energie cu care sã vibreze la unison, dupã principiul "ceea ce se aseamãnã se adunã".
Fiecare gând, indiferent cã este bun sau rãu, declanºeazã un proces de rezonanþã. Tot ceea ce va vibra la unison cu energia gândurilor noastre va fi atras automat în viaþa noastrã.
Gândurile tale secrete, felul în care îi judeci pe ceilalþi, vorbãria interminabilã a minþii - totul formeazã un fel de intenþie.
Aºadar, prin gândurile noastre, noi emitem permanent energie cãtre exterior, fapt care influenþeazã într-o mare mãsurã ceea ce atragem în viaþa noastrã. De aceea, o scanare atentã a propriilor gânduri, mai ales a celor despre noi înºine, ne ajutã sã conºtentizãm ce anume avem de schimbat. ªtiþi ce este minunat aici? Faptul cã stã în puterea noastrã sã ne alegem gândurile. Precum la un televizor, putem comuta pe diferite programe, iar dacã v-aþi sãturat de emisiunea "Sunt un prost. Nu fac nimic cum trebuie", apãsaþi butonul ºi alegeþi "Dragostea lui Dumnezeu mã înconjoarã ºi mã susþine în fiecare clipã a vieþii". Veþi simþi diferenþa.
1. În crearea realitãþii noastre, nu doar gândul este "implicat". Mai este ºi altceva.
Pânã nu demult, oamenii de ºtiinþã au crezut cã doar prin gândurile noastre emitem energie cãtre exterior ºi cã cel mai puternic emiþãtor energetic din corpul nostru ar fi creierul, cu impulsurile sale electromagnetice.
Dar trupul nostru dispune de un emiþãtor ºi mai puternic - INIMA - care genereazã un câmp electric mult mai mare decât cel al creierului. Aceasta este una dintre cele importante descoperiri ale secolului XX: faptul cã inima omeneascã are un rol mult mai important decât acela de a pompa sânge în corpul uman.
Responsabil pentru aceastã descoperire este Institutul de Cardiologie din California care a realizat un studiu aprofundat al inimii. Astfel s-a descoperit faptul cã acest organ uman este înzestrat cu ceea ce numim"inteligenþa inimii" ºi cã influenþele acesteia sunt foarte profunde pentru noi.
Mãsurãtorile realizate au arãtat cã inima generazã un câmp electric care se extinde cu mult în afara corpului nostru. Acest câmp electric are o anumitã formã, aratând ca un inel lat împrejurul trupului, cu o razã de aproximativ 2-3 metri.
Institutul de Cardiologie a mai descoperit cã inima interacþioneazã atât cu trupul, cât ºi cu mediul exterior prin câmpurile electromagnetice pe care le genereazã. Avem motive sã credem cã acest câmp generat de inimã are influenþã la mulþi kilometri în afara corpului nostru, pornind de la locaþia fizicã a inimii. Cum poate inima sã facã aceasta? În ce fel comunicã ea? Cum sunt transmise informaþiile?
În primul rând prin EMOÞII.
ªtiinþa ne spune cã atunci când simþim o emoþie, ea este transpusã în energii electrice ºi magnetice corespunzãtoare, care interacþioneazã cu celulele corpului nostru ºi cu atomii lumii înconjurãtoare pentru a produce acele efecte formidabile de care vorbesc toate tradiþiile spirituale autentice. Ele ºtiu cum sã orienteze atenþia aspirantului cãtre inimã, pe când noi o orientãm cãtre raþiune, creând astfel o societate foarte mentalã, bazatã doar pe logicã.
Alte studii asupra inimii au arãtat cã aceste câmpuri electromagnetice generate de inimã au ºi o altã cauzã la fel de importantã ºi anume CONVINGERILE noastre, toate acele lucruri pe care le credem cu tãrie ºi în jurul cãrora ne modelãm vieþile.
Deci nu numai emoþiile noastre sunt emise în afarã, ci mai ales convingerile noastre. Iar inima este un fel de interfaþã care transformã toate emoþiile ºi convingerile noastre în energii electromagnetice.
Deci prin sentimentele noastre, prin iubire, iertare, compasiune, dar ºi prin mânie, urã, supãrare, noi putem produce modificãri atât în trupul nostru, cât ºi la mulþi kilometri în afara noastrã.
Trãgând linie, este bine sã reþinem urmãtorul aspect: deºi creierul emite ºi el câmpuri electromagnetice, oamenii de ºtiinþã au arãtat cã undele electrice produse de inimã sunt de o sutã de ori mai puternice, iar undele magnetice sunt de 5.000 de ori mai puternice decât cele generate de creier.
Astfel se explicã de ce vindecarea se obþine mai repede printr-o susþinere afectivã decât doar printr-un proces de gândire, pentru cã noi emitem mai multã energie prin intermediul inimii decât prin intermediul creierului.
2. ADN-ul uman are o influenþã directã asupra lumii înconjurãtoare Existã încã o descoperire ºtiinþificã importantã care ne aratã cum influenþãm realitatea în care trãim.
ªtim, teoretic, cã totul este interconectat ºi în mod tainic interdependent. Dar sã vedem cum se traduce aceastã lege, la nivelul micro-universului nostru.
Studiile de laborator au arãtat cã ADN-ul uman influenþeazã direct substanþa din care sunt formaþi atomii, adicã niºte particule micuþe de luminã, numite fotoni.
Fizicianul rus Vladimir Poponin a realizat niºte experimente faimoase la începutul anilor '90. El a pus într-o eprubetã închisã ADN uman ºi fotoni, dorind sã afle ce influenþã are ADN-ul uman asupra fotonilor. Dintr-una dintre eprubete s-a extras tot aerul, pentru a obþine "vid" (vidul este un termen care induce în eroare, deoarece el nu este un spaþiu gol, ci este plin de informaþii ºi energie). Într-un astfel de spaþiu existã fotoni care pot fi mãsuraþi destul de exact cu unele aparate specifice.
În experimentul lui Poponin, aceºti fotoni s-au distribuit, aºa cum era de aºteptat, în mod dezordonat, fãrã sã respecte o anumitã ordine.
Apoi a fost introdus ADN uman în aceastã eprubetã vidatã. ªi acum s-a produs un lucru foarte surprinzãtor. ADN-ul uman avea o influenþã directã asupra fotonilor: printr-o forþã misterioasã, el ordona fotonii în forme regululate. Acest aspect este foarte, foarte profund, deoarece aratã cã substanþa din care suntem creaþi, adicã ADN-ul, are o influenþã directã asupra particulelor din care este creatã lumea înconjurãtoare, adicã fotonii atomilor. Este prima datã când ºtiinþa occidentalã a demonstrat ceea ce tradiþiile spirituale strãvechi au spus cu mult timp în urmã: suntem parte integrantã din aceastã lume ºi o influenþãm în permanenþã.
Iar experimentul nu se opreºte aici. Când ADN-ul uman a fost extras din eprubetã, fotonii s-au comportat ca ºi cum ADN-ul era încã prezent acolo. ªi-au pãstrat poziþia lor ordonatã. Fotonii ºi ADN-ul uman încã mai pãstrau legãtura, deºi fuseserã separaþi fizic. Pãrea cã un anume câmp subtil încã le þinea conectate.
Concluzia experimentului lui Poponin a fost aceea cã existã un câmp cuantic care ne uneºte cu tot ceea ce existã în jurul nostru. Prin intermediul acestui câmp, suntem mereu în legãturã cu toþi ºi cu toate, fie cã suntem conºtienþi sau nu de aceasta.
3. ADN-ul uman este influenþat, la rândul sãu, de sentimente.
Senimentele umane care izvorãsc din inimã, având în spate convingerile noastre puternice, modificã efectiv forma ADN-ului, iar acesta influenþeazã atomii, dupã cum am vãzut.
S-au testat efectele sentimentelor pure asupra ADN-ului. Pentru aceasta a fost izolat ADN de la diferite persoane în câte o eprubetã. Aceste eprubete cu ADN au fost supuse unor puternice câmpuri emoþionale. Pentru aceasta, subiecþii experimentului au folosit diferite tehnici emoþionale ºi spirituale.
S-a observat un lucru care, protrivit vechilor legi ale fizicii, nu ar fi trebuit sã se petreacã. În timp ce participantul emitea un câmp emoþional puternic, au putut fi mãsurate reacþii electrice la nivelul ADN-ului. Persoanele care au participat la acest test puteau influenþa molecula de ADN din eprubetã doar prin intermediul emoþiilor lor puternice.
Când subiecþii experimentului emiteau stãri de iubire, recunoºtinþã, molecula de ADN se dilata, lanþurile ADN-ului se deschideau, se mãreau.
Când subiecþii respectivi trãiau stãri de furie, frustrare, stres, molecula de ADN se micºora ºi bloca astfel multe din codurile sale, rãspunzând emoþiilor negative printr-o evidentã contracþie.
S-a observat astfel, în mod empiric, cum emoþiile, convingerile, sentimentele noastre pot modifica structura moleculei de ADN, precum ºi ordonarea acesteia în celule.
Mai mult chiar, oamenii de ºtiinþã au remarcat cã aceastã blocare a codurilor ADN putea fi anulatã deîndatã ce experimentatorii emiteau din nou stãri de recunoºtinþã, iubire ºi fericire. Aceste descoperiri, care au arãtat cã genele ADN-ului sunt modificate de energiile din exterior, stau la baza întemeierii unei noi ºtiinþe, denumitã Epigeneticã. Creierul este un centru de comandã care interpreteazã evenimentele din exterior ºi apoi trimite în trup semnale corespunzãtoare. Printre aceste semnale se numãrã atât reacþiile biochimice, cât ºi undele electromagnetice. Aceste semnale influenþeazã în mod direct celulele ºi produc astfel modificãri ale codurilor lor genetice.
Cu ajutorul unui ceas atomic foarte precis, s-a mãsurat diferenþa de timp dintre emiterea unei emoþii ºi reacþia ADN-ului. S-a observat cã reacþia ADN-ului avea loc întotdeauna simultan.
Tot ceea ce gândim ºi simþim, ADN-ul nostru percepe în mai puþin de o nanosecundã (0,000000001 secunde), iar aceasta indiferent dacã mostra de ADN se aflã lângã noi sau pe cealaltã parte a Pãmântului. Concluzia?
Gândurile ºi sentimentele noastre pot modifica ADN-ul, iar ADN-ul modificã în mod direct materia din care este structuratã lumea. Atunci când trãim anumite stãri, cum ar fi, de exemplu, compasiune, iertare, dragoste, dar ºi stãri negative, ca de exemplu mânie urã, supãrare, gelozie, noi influenþãm direct structura ADN-ului nostru, iar aceste modificãri se propagã în trupul nostru, cât ºi în afara noastrã pe distanþe extraordinar de mari, datoritã câmpului cuantic, influenþând tot ceea ce existã în aceastã lume.
Fragmente din FILMUL "Legea rezonanþei"
În documentar apar oamenii de stiinta: Dr. Bruce H. Lipton, Gregg Braden, dr. Rupert Sheldrake, Prof. Dr. Dr. Ervin Laszlo, Prof. Dr. Fritz A. Popp, Lynn McTaggart Bärbel Mohr, Prof. Dr. James Hurtak, Dr. Masaru Emoto, dr. Eric Pearl, prof. dr. Hans-Peter Dürr, Dr. James L. Oschman, Dr. John Hinwood, Dr. James M. Sigafoose, Patricia Atanas, Dr. Peter Bancel, Renée Coltson, dr. Desiree Hurtak, Anna Rocker, Isabelle de Fallois, Michaela Merten, Julia Franckh, Fantuzzi, Lionel Wharton si Max Alberti.

Articol preluat de pe Financiarul - http://www.financiarul.ro/ Link catre articol: http://www.financiarul.ro/2011/11/19/3-descoperiri-ale-fizicii-cuantice-cu-impact-major-asupra-vietii-noastre/

* riperidona pe termen lung

Conclusions: Patients with schizophrenia who were initiated on RLAT demonstrated improvements in measures of effectiveness within 3 months, which persisted over 24 months.

* insight in schizofrenie

Abstract: Patients with deficit schizophrenia have worse cognition and poorer social functioning compared with those with nondeficit schizophrenia. Insight is another domain in which these two groups might differ. However, there is no literature data specifically on cognitive insight impairment in deficit versus nondeficit schizophrenia. We compared 40 patients with deficit schizophrenia with 81 nondeficit patients and found that schizophrenic patients with deficit syndrome were more self-reflective and have higher self-reflectiveness−self-certainty index scores than did those without deficit syndrome. These differences remained significant when analysis was controlled for sex, age, education, and depression severity. On the other hand, there was no significant difference in self-certainty scores between two groups. In addition, we found significant relationships between cognitive insight and specific psychotic symptoms. A better understanding of the cognitive component of insight in schizophrenia with deficit syndrome may help us to understand the true relationship between insight and negative symptoms and contribute to the development of more efficient cognitive strategies, thus improving patients’ outcome in a severely disabled psychiatric patient group.

Psychotherapy for gender identity disorders

Author Affiliations

Az Hakeem trained in both forensic psychiatry and psychotherapy before taking up his current consultant posts with Camden and Islington NHS Foundation Trust and the Tavistock and Portman NHS Foundation Trust. He is an acute in-patient consultant, the head of a mentalisation-based therapy service for borderline personality disorder and, since 2001, has run the UK specialist service offering psychotherapy for people with gender identity disorders. He has trained as a group analyst and has worked as a psychiatrist for the media on a number of television programmes

Correspondence Dr Az Hakeem, Highgate Mental Health Centre, Dartmouth Park Hill, London N19 5NX, UK. Email: az@drazhakeem.com

SUMMARY

This article describes a special adaptation of group psychotherapy as a psychological treatment for people with a variety of gender identity disorders. It can be used as an alternative to or concurrently with hormonal and/or surgical interventions for transgender people. It is also suitable for individuals whose gender identity disorder remains after physical interventions. The article draws from a UK specialist pilot for such a treatment service and describes the explicit aims of the psychotherapy, the specialist adaptation of therapeutic technique required and observed thematic features relevant to working in this specific field.

* Parkinson

Our findings suggest that depression and motor symptoms/well-being are highly intertwined in patients with PD.

* hormonul adponectin

January 6, 2012 — New data from the Framingham Heart Study hint that an elevation in adiponectin level may be an independent risk factor for all-cause dementia and Alzheimer's disease (AD) in women.

* rispperidol la copii

January 5, 2012 — A new study shows that the antipsychotic drug risperidone is significantly superior to lithium and divalproex sodium for initial treatment of mania in children, and it is better tolerated, although this drug has potentially serious metabolic effects that raise concerns about its long-term use

* Insulina in Alzheimer

Alzheimer's disease (AD) is linked to CNS insulin resistance, decreased expression of insulin and insulin receptor genes, and lower cerebrospinal insulin levels. Against this background, impaired brain insulin signaling may account for some of the cognitive deficits associated with this disease. Using the intranasal method, which effectively bypasses the blood–brain barrier to deliver and target insulin directly from the nose to the brain, a series of acute clinical trials involving healthy humans and AD patients have shown that increased CNS insulin action enhances learning and memory processes. This article summarizes and evaluates data from a recently published clinical trial, in which 4 months of intranasal insulin administration (20 IU insulin/day) preserved not only general cognition but also reduced the loss of metabolic integrity of the brain in adults with mild-to-moderate AD.

* Alzheimer - 2025

CHICAGO (Reuters) Jan 19 - The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer's disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS.

* citalopram maxim 40 mg.

August 24, 2011 — The antidepressant citalopram (Celexa, Forest Laboratories) should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration warns

* riscul de SUICID

Recognizing Suicide Risk Factors in Primary and Psychiatric Care

Larry Culpepper, MD, MPH

Authors and Disclosures

Posted: 10/25/2010

Suicidality and Suicide in Primary Care: Introduction
Should You Ask About Suicidal Ideation?
Risk Factors: What to Look Out For
I've Detected Risk Factors: Now What?
How To Manage Risk Factors

References

Suicidality and Suicide in Primary Care: Introduction

In those with major depression, the risk for suicide is increased 20-fold compared with the general population.^[1] A history of major depression is present in about 60% of those who complete suicides. An estimated 8% of those with major depression attempt suicide at some time during their lifetime. This rate is increased in those with comorbid anxiety disorders (eg, 25% with comorbid panic disorder and 38% in those with comorbid posttraumatic stress syndrome disorder).^[2] About 31,000 people in the United States and 1 million worldwide die by suicide each year, and 650,000 people in the United States are treated emergently following a suicide attempt

* relatia testosteron-hipertensiune arteriala

Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy
International Journal of Impotence Research, 01/20/2012 Clinical Article

Garcia–Cruz E et al. – Levels of testosterone were related to hypertension, dyslipidemia, overweight and the number of cardiovascular risk factors. The prevalence of Testosterone deficiency syndrome in the population is comparable to data from international studies. Testosterone levels decrease as the number of cardiovascular risk factors rise.

* Antidepresivele nu sunt indicate in distimii

Sub-threshold Depression and Antidepressants Use in a Community Sample

Searching Anxiety and Finding Bipolar Disorder

Mauro G Carta; Leonardo Tondo; Matteo Balestrieri; Filippo Caraci; Liliana dell'Osso; Guido Di Sciascio; Carlo Faravelli; Maria C Hardoy; Maria E Lecca; Maria F Moro; Krishna M Bhat; Massimo Casacchia; Filippo Drago

Authors and Disclosures

Abstract and Introduction

Abstract

Background: To determine the use of antidepressants (ADs) in people with sub-threshold depression (SD); the lifetime prevalence of mania and hypomania in SD and the link between ADs use, bipolarity and anxiety disorders in SD.

Methods: Study design: community survey. Study population: samples randomly drawn, after stratification from the adult population of municipal records. Sample size: 4999 people from seven areas within six Italian regions. Tools: Questionnaire on psychotropic drug consumption, prescription; Structured Clinical Interview NP for DSM-IV modified (ANTAS); Hamilton Depression Rating Scale (HAM-D); Mood Disorder Questionnaire (MDQ); Short Form Health Survey (SF-12). SD definition: HAM-D > 10 without lifetime diagnosis of Depressive Episode (DE).

Results: SD point prevalence is 5.0%. The lifetime prevalence of mania and hypomania episodes in SD is 7.3%. Benzodiazepines (BDZ) consumption in SD is 24.1%, followed by ADs (19.7%). In SD, positive for MDQ and comorbidity with Panic Disorder (PD) or Generalized Anxiety Disorders (GAD) are associated with ADs use, whereas the association between a positive MDQ and ADs use, without a diagnosis of PD or GAD, is not significant. Only in people with DE the well-being (SF-12) is higher among those using first-line antidepressants compared to those not using any medication. In people with SD no significant differences were found in terms of SF-12 score according to drug use.

Conclusions: This study suggests caution in prescribing ADs to people with SD. In people with concomitant anxiety disorders and SD, it should be mandatory to perform a well-designed assessment and evaluate the presence of previous manic or hypomanic symptoms prior to prescribing ADs

Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy
International Journal of Impotence Research, 01/20/2012 Clinical Article

How Are Second-Generation Antipsychotics Advancing the Treatment of Depression? CPD

Assess new data/evidence-base for the use of atypical antipsychotics as a treatment option in patients with unipolar and bipolar depression.

Did you miss this CME/CE Activity?

Clinic Management and Leadership to Improve Treatment With Antipsychotics CME/CE

Assess methods for aligning clinical procedures and policies with guidelines for metabolic screening.

UpToDate - February


* Most Emailed Articles on Medscape
1.	A Matter of Respect and Dignity: Bullying in the Nursing Profession Medscape Nurses
2.	Vitamin D Supplementation: An Update US Pharmacist
3.	Overhauling Nursing Education Medscape Nurses
4.	The 2010 AHA Guidelines: The 4 Cs of Cardiac Arrest Care Medscape Emergency Medicine
5.	The Downward Spiral: Incivility in Nursing Medscape Nursesµ

*Most Emailed Articles on Medscape
1.	A Matter of Respect and Dignity: Bullying in the Nursing Profession Medscape Nurses
2.	Vitamin D Supplementation: An Update US Pharmacist
3.	Overhauling Nursing Education Medscape Nurses
4.	The 2010 AHA Guidelines: The 4 Cs of Cardiac Arrest Care Medscape Emergency Medicine
5.	The Downward Spiral: Incivility in Nursing Medscape Nurses


**Most Emailed Articles on Medscape
1.	A Matter of Respect and Dignity: Bullying in the Nursing Profession Medscape Nurses
2.	Vitamin D Supplementation: An Update US Pharmacist
3.	Overhauling Nursing Education Medscape Nurses
4.	The 2010 AHA Guidelines: The 4 Cs of Cardiac Arrest Care Medscape Emergency Medicine
5.	The Downward Spiral: Incivility in Nursing Medscape Nurses


Most Emailed Articles on Medscape
1.	A Matter of Respect and Dignity: Bullying in the Nursing Profession Medscape Nurses
2.	Vitamin D Supplementation: An Update US Pharmacist
3.	Overhauling Nursing Education Medscape Nurses
4.	The 2010 AHA Guidelines: The 4 Cs of Cardiac Arrest Care Medscape Emergency Medicine
5.	The Downward Spiral: Incivility in Nursing Medscape Nurses

UptoDate - February

BJP -- Future Table of Contents Alert

A new future TOC for The British Journal of Psychiatry is available online for the issue:

March 2012; Vol. 200, No. 3

This Future Table of Contents is available online at: http://bjp.rcpsych.org/future/200.3.shtml

These articles have been accepted for this issue. Change is possible before publication.
Editorials
Psychopathy in childhood: is it a meaningful diagnosis?

M. Rutter The British Journal of Psychiatry 2012 200 (3)

Why should we care about measuring callous-unemotional traits in children?

E. Viding and E. J. McCrory The British Journal of Psychiatry 2012 200 (3)

Comorbid anxiety and depression: bete noire or quick fix?

C. Andreescu and E. J. Lenze The British Journal of Psychiatry 2012 200 (3)

The Equality Act 2010 and mental health

G. Lockwood, C. Henderson and G. Thornicroft The British Journal of Psychiatry 2012 200 (3)

Review article

Group psychological therapies for depression in the community: systematic review and meta-analysis

A. L. Huntley, R. Araya and C. Salisbury The British Journal of Psychiatry 2012 200 (3)

Papers

Love, eye contact and the developmental origins of empathy v. psychopathy

M. R. Dadds, J. L. Allen, B. R. Oliver, N. Faulkner, K. Legge, C. Moul, M. Woolgar and S. Scott The British Journal of Psychiatry 2012 200 (3)

Adolescent callous-unemotional traits and conduct disorder in adoptees exposed to severe early deprivation

R. Kumsta, E. Sonuga-Barke and M. Rutter The British Journal of Psychiatry 2012 200 (3)

Prenatal exposure to tobacco and future nicotine dependence: population-based cohort study

M. Rydell, S. Cnattingius, F. Granath, C. Magnusson and M. R. Galanti The British Journal of Psychiatry 2012 200 (3)

Effects of anxiety on the long-term course of depressive disorders

W. Coryell, J. G. Fiedorowicz, D. Solomon, A. C. Leon, J. P. Rice and M. B. Keller The British Journal of Psychiatry 2012 200 (3)

Factors associated with mental disorders in long-settled war refugees:

M. Bogic, D. Ajdukovic, S. Bremner, T. Franciskovic, G. M. Galeazzi, Abdulah Kucukalic, D. Lecic-Tosevski, N. Morina, M. Popovski, M. Schutzwohl, D. Wang and S. Priebe The British Journal of Psychiatry 2012 200 (3)

Brief eclectic psychotherapy v. eye movement desensitisation and reprocessing therapy in the treatment of post-traumatic stress disorder: randomised controlled trial

M. J. Nijdam, B. P. R. Gersons, J. B. Reitsma, A. de Jonge and M. Olff The British Journal of Psychiatry 2012 200 (3)

Long-term efficacy of psychological treatments for binge eating disorder

A. Hilbert, M. E. Bishop, E. I. Stein, M. Tanofsky-Kraff, A. K. Swenson, R. R. Welch and D. E. Wilfley The British Journal of Psychiatry 2012 200 (3)

Implications for psychedelic-assisted psychotherapy: a functional magnetic resonance imaging study with psilocybin

R. L. Carhart-Harris, R. Leech, T. M. Williams, D. Erritzoe, N. Abbasi, T. Bargiotas, P. Hobden, D. J. Sharp, J. Evans, A. Feilding, R. G. Wise and D. J. Nutt The British Journal of Psychiatry 2012 200 (3)

Trends in national suicide rates for Scotland and for England and Wales, 1960-2008

P. L. H. Mok, N. Kapur, K. Windfuhr, A. H. Leyland, L. Appleby, S. Platt and R. T. Webb The British Journal of Psychiatry 2012 200 (3)

UpToDate - Februay

BJP -- Future Table of Contents Alert

A new future TOC for The British Journal of Psychiatry is available online for the issue:

February 2012; Vol. 200, No. 2

This Future Table of Contents is available online at: http://bjp.rcpsych.org/future/200.2.shtml

These articles have been accepted for this issue. Change is possible before publication.

Editorials

Negative childhood experiences and mental health: theoretical, clinical and primary prevention implications

J. Read and R. P. Bentall The British Journal of Psychiatry 2012 200 (2)

Antibody-mediated encephalitis: a treatable cause of schizophrenia

B. R. Lennox, A. J. Coles and A. Vincent The British Journal of Psychiatry 2012 200 (2)

Setting the bar: athletes and vulnerability to mental illness

L. Hughes and G. Leavey The British Journal of Psychiatry 2012 200 (2)

Review article

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

S. Leucht, S. Hierl, W. Kissling, M. Dodd and J. M. Davis The British Journal of Psychiatry 2012 200 (2)

Papers

Childhood maltreatment and the structure of common psychiatric disorders

K. M. Keyes, N. R. Eaton, R. F. Krueger, K. A. McLauchlin, M. M. Wall, B. F. Grant and D. S. Hasin The British Journal of Psychiatry 2012 200 (2)

Moderating role of the MAOA genotype in antisocial behaviour

D. M. Fergusson, J. M. Boden, L. John Horwood, A. Miller and M. A. Kennedy The British Journal of Psychiatry 2012 200 (2)

Relative impact of maternal depression and associated risk factors on offspring psychopathology

E. D. Barker, W. Copeland, B. Mauchan, S. R. Jaffee and R. Uher The British Journal of Psychiatry 2012 200 (2)

Severity of depression and response to antidepressants: GENPOD randomised controlled trial

N. J. Wiles, J. Mulligan, T. J. Peters, P. J. Cowen, V. Mason, D. Nutt, D. Sharp, D. Tallon, L. Thomas, M. C. O'Donovan and G. Lewis The British Journal of Psychiatry 2012 200 (2)

Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction

J. F. Scherrer, T. Chrusciel, L .D. Garfield, K. E. Freedland, R. M. Carney, P. J. Hauptman, K. K. Bucholz, R. Owen The British Journal of Psychiatry 2012 200 (2)

Mortality in people with depressive, anxiety and alcohol use disorders in Finland

N. Markkula, T. Harkanen, J. Perala, K. Partti, S. Pena, S. Koskinen, J. Lonnqvist, J. Suvisaari and S. I. Saarni The British Journal of Psychiatry 2012 200 (2)

Regional cerebral blood flow in late-life depression: arterial spin labelling magnetic resonance study

S. J. Colloby, M. J. Firbank, J. He, A. J. Thomas, A. Vasudev, S. W. Parry and J. T. O'Brien The British Journal of Psychiatry 2012 200 (2)

Short reports

Psychosis incidence through the prism of early intervention services

J. B. Kirkbride, C. Stubbins and P. B. Jones The British Journal of Psychiatry 2012 200 (2)

Mental health outcomes of widowed and married mothers after war

N. Morina and P. M. G. Emmelkamp The British Journal of Psychiatry 2012 200 (2)

UpToDate - February

Current Issue

< Previous Issue

The American Journal of Psychiatry

January 01, 2012, Vol. 169, No. 1

Get Alert | RSS

Listen to the Podcast | All Podcasts

Download PDFs: Cover Table of Contents Editorial Board Front Matter Back Matter

PSYCHIATRY&CLINICAL PSYCHOLOGY Romanian Free Psychiatrists Association(APLR)-APRIL 2025

* riperidona pe termen lung

Conclusions: Patients with schizophrenia who were initiated on RLAT demonstrated improvements in measures of effectiveness within 3 months, which persisted over 24 months.

* insight in schizofrenie

Psychotherapy for gender identity disorders

SUMMARY

* riscul de SUICID

Recognizing Suicide Risk Factors in Primary and Psychiatric Care

Suicidality and Suicide in Primary Care: Introduction

* relatia testosteron-hipertensiune arteriala

* Antidepresivele nu sunt indicate in distimii

Sub-threshold Depression and Antidepressants Use in a Community Sample

Searching Anxiety and Finding Bipolar Disorder

Abstract and Introduction

Abstract

Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy International Journal of Impotence Research, 01/20/2012 Clinical Article

UpToDate - February

UptoDate - February

UpToDate - Februay

UpToDate - February

Despre APLR

Blog Archive

Related links

Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy
International Journal of Impotence Research, 01/20/2012 Clinical Article